Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love Smith & Nephew plc (ADR) (SNN)?

Page 1 of 2

Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on an average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The time period between June 25 and the end of October was one of those periods, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 14 percentage points. Given that the funds we track tend to have a disproportionate amount of their portfolios in smaller cap stocks, they have seen some volatility in their portfolios too. Actually, their moves are potentially one of the factors that contributed to this volatility. In this article, we use our extensive database of hedge fund holdings to find out what the smart money thinks of Smith & Nephew plc (ADR) (NYSE:SNN).

Is Smith & Nephew plc (ADR) (NYSE:SNN) a bargain? The smart money is in a pessimistic mood. The number of long hedge fund positions shrunk by 7 in recent months. Smith & Nephew plc (ADR) (NYSE:SNN) was in 14 hedge funds’ portfolios at the end of September. There were 21 hedge funds in our database with Smith & Nephew plc (ADR) (NYSE:SNN) holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Shinhan Financial Group Co., Ltd. (ADR) (NYSE:SHG), WEC Energy Group Inc (NYSE:WEC), and Nielsen N.V. Ordinary Shares (NYSE:NLSN) to gather more data points.

Follow Smith & Nephew P L C (NYSE:SNN)
Trade (NYSE:SNN) Now!

In the financial world, there are many formulas stock traders have at their disposal to size up their holdings. Two of the most under-the-radar formulas are hedge fund and insider trading interest. Our researchers have shown that, historically, those who follow the best picks of the elite investment managers can beat the broader indices by a superb margin (see the details here).

With all of this in mind, let’s take a look at the key action encompassing Smith & Nephew plc (ADR) (NYSE:SNN).

What does the smart money think about Smith & Nephew plc (ADR) (NYSE:SNN)?

At the end of September, a total of 14 of the hedge funds tracked by Insider Monkey were long this stock, a decline of 33% from one quarter earlier. With the smart money’s capital changing hands, there exists a select group of notable hedge fund managers who were increasing their stakes substantially (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Fisher Asset Management, managed by Ken Fisher, holds the biggest position in Smith & Nephew plc (ADR) (NYSE:SNN). Fisher Asset Management has a $76.7 million position in the stock, comprising 0.2% of its 13F portfolio. On Fisher Asset Management’s heels is Eton Park Capital, managed by Eric Mindich, which holds a $19.9 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Remaining peers with similar optimism contain Israel Englander’s Millennium Management, D E Shaw, and John Overdeck and David Siegel’s Two Sigma Advisors.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!